GVN works closely with national and international scientific institutions, government agencies, academic centers, and industry collaborators to strengthen global resilience against viral diseases. These partnerships expand research capacity, enhance diagnostics and surveillance, and support unified efforts to prepare for and respond to emerging pathogens.
Corporate Partners
The business and institutional communities are integral partners in strengthening global preparedness against viral threats. Outbreaks such as SARS-CoV-2 / COVID-19 know no boundaries, spreading rapidly across countries and disrupting societies, economies, and workforces. Multinational corporations, businesses, and institutions with global reach are vital partners in advancing solutions to current and future pandemics.
The goal of these partnerships is to connect organizations with leading virologists, enabling collaboration on research, diagnostics, therapeutics, vaccines, and training, while strengthening global readiness and response.
Institutional Partners
Institutional Partners:
Coalition for Epidemic Preparedness Innovations (CEPI)
European Research Infrastructure on Highly Pathogenic Agents (ERINHA)
International Readiness For Preventing Infectious Viral Disease (INTREPID)
Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)